Nicole DelRosso

Nicole DelRosso

Auto-generated profile, based on publicly available information

Nicole DelRosso

Biophysics Program, Stanford University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NDNicole DelRosso
Nicole DelRosso
PSPeter H. Suzuki
Peter H. Suzuki
DGDaniel Griffith
Daniel Griffith
JLJeffrey M. Lotthammer
Jeffrey M. Lotthammer
BNBorna Novak
Borna Novak
PFPolly Fordyce
Polly Fordyce
Sequence-specific activation by transcription factors is essential for gene regulation 1,2 . Key to this are activation domains, which often fall within disordered regions of transcription factors 3,4 and recruit co-activators to initiate transcription 5 . These interactions are difficult to characterize via most experimental techniques because they are typically weak and transient 6,7 . Consequently, we know very little about whether these interactions are promiscuous or specific, the mechanisms of binding, and how these interactions tune the strength of gene activation. To address these questions, we developed a microfluidic platform for expression and purification of hundreds of activation domains in parallel followed by direct measurement of co-activator binding affinities (STAMMPPING, for Simultaneous Trapping of Affinity Measurements via a Microfluidic Protein-Protein INteraction Generator). By applying STAMMPPING to quantify direct interactions between eight co-activators and 204 human activation domains (>1,500 K d s), we provide the first quantitative map of these interactions and reveal 334 novel binding pairs. We find that the metazoan-specific co-activator P300 directly binds >100 activation domains, potentially explaining its widespread recruitment across the genome to influence transcriptional activation. Despite sharing similar molecular properties ( e.g. enrichment of negative and hydrophobic residues), activation domains utilize distinct biophysical properties to recruit certain co-activator domains. Co-activator domain affinity and occupancy are well-predicted by analytical models that account for multivalency, and in vitro affinities quantitatively predict activation in cells with an ultrasensitive response. Not only do our results demonstrate the ability to measure affinities between even weak protein-protein interactions in high throughput, but they also provide a necessary resource of over 1,500 activation domain/co-activator affinities which lays the foundation for understanding the molecular basis of transcriptional activation.

14 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
JTJosh Tycko
Josh Tycko
MVMike V. Van
Mike V. Van
ARAradhana
Aradhana
NDNicole DelRosso
Nicole DelRosso
DYDavid Yao
David Yao
MBMichael C. Bassik
Michael C. Bassik
Human nuclear proteins contain >1000 transcriptional effector domains that can activate or repress transcription of target genes. We lack a systematic understanding of which effector domains regulate transcription robustly across genomic, cell-type, and DNA-binding domain (DBD) contexts. Here, we developed dCas9-mediated high-throughput recruitment (HT-recruit), a pooled screening method for quantifying effector function at endogenous targets, and tested effector function for a library containing 5092 nuclear protein Pfam domains across varied contexts. We find many effectors depend on target and DBD contexts, such as HLH domains that can act as either activators or repressors. We then confirm these findings and further map context dependencies of effectors drawn from unannotated protein regions using a larger library containing 114,288 sequences tiling chromatin regulators and transcription factors. To enable efficient perturbations, we select effectors that are potent in diverse contexts, and engineer (1) improved ZNF705 KRAB CRISPRi tools to silence promoters and enhancers, and (2) a compact human activator combination NFZ for better CRISPRa and inducible circuit delivery. Together, this effector-by-context functional map reveals context-dependence across human effectors and guides effector selection for robustly manipulating transcription.

26 August 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
NDNicole DelRosso
Nicole DelRosso
JTJosh Tycko
Josh Tycko
PSPeter Suzuki
Peter Suzuki
CACecelia Andrews
Cecelia Andrews
ARAradhana
Aradhana
LBLacramioara Bintu
Lacramioara Bintu
Summary: Human gene expression is regulated by over two thousand transcription factors and chromatin regulators 1,2 . Effector domains within these proteins can activate or repress transcription. However, for many of these regulators we do not know what type of transcriptional effector domains they contain, their location in the protein, their activation and repression strengths, and the amino acids that are necessary for their functions. Here, we systematically measure the transcriptional effector activity of >100,000 protein fragments (each 80 amino acids long) tiling across most chromatin regulators and transcription factors in human cells (2,047 proteins). By testing the effect they have when recruited at reporter genes, we annotate 307 new activation domains and 592 new repression domains, a ∼5-fold increase over the number of previously annotated effectors 3,4 . Complementary rational mutagenesis and deletion scans across all the effector domains reveal aromatic and/or leucine residues interspersed with acidic, proline, serine, and/or glutamine residues are necessary for activation domain activity. Additionally, the majority of repression domain sequences contain either sites for SUMOylation, short interaction motifs for recruiting co-repressors, or are structured binding domains for recruiting other repressive proteins. Surprisingly, we discover bifunctional domains that can both activate and repress and can dynamically split a cell population into high- and low-expression subpopulations. Our systematic annotation and characterization of transcriptional effector domains provides a rich resource for understanding the function of human transcription factors and chromatin regulators, engineering compact tools for controlling gene expression, and refining predictive computational models of effector domain function.

16 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
RHRenee Hastings
Renee Hastings
AAArjun Aditham
Arjun Aditham
NDNicole DelRosso
Nicole DelRosso
PSPeter Suzuki
Peter Suzuki
PFPolly Fordyce
Polly Fordyce
Transcription factors (TFs) bind DNA sequences with a range of affinities, yet the mechanisms determining energetic differences between high- and low-affinity sequences (‘selectivity’) remain poorly understood. Here, we investigated two basic helix-loop-helix TFs, MAX (H. sapiens) and Pho4 (S. cerevisiae) , that bind the same high-affinity sequence with highly similar nucleotide-contacting residues and bound structures but are differentially selective for non-cognate sequences. By measuring >1700 K d s and >500 rate constants for Pho4 and MAX mutant libraries binding multiple DNA sequences and comparing these measurements with thermodynamic and kinetic models, we identify the biophysical mechanisms by which changes to TF sequence alter both bound and unbound conformational ensembles to shape specificity landscapes. These results highlight the importance of conformational heterogeneity in determining sequence specificity and selectivity and can guide future efforts to engineer nucleic acid-binding proteins with enhanced selectivity.

12 December 2025 in bioRxiv
Verified
Preprint
Open access
CACecelia J Andrews
Cecelia J Andrews
ECEli J Costa
Eli J Costa
GCGeovanni L Janer Carattini
Geovanni L Janer Carattini
NDNicole V DelRosso
Nicole V DelRosso
TFTaihei Fujimori
Taihei Fujimori
LBLacramioara Bintu
Lacramioara Bintu
Dynamic gene expression pulses enable adaptive response to stimuli and can be generated in natural and synthetic systems. Controlling these dynamics typically involves circuits consisting of multiple genes and transcription factors (TFs). Here, we discover a new class of bifunctional transcriptional effector domains that can first activate and subsequently repress the same gene, producing dynamic gene expression pulses from a single input. These pulse dynamics arise from distinct, temporally separated chromatin states defined by active and repressive chromatin modifications. The balance between active and repressed states is determined by the DNA occupancy of the bifunctional TF. Bifunctional domains activate at low occupancy but switch to repression at high occupancy, resulting in a non-monotonic TF input-gene expression output relationship tunable by TF concentration and number of DNA binding sites. We develop a kinetic model that links TF occupancy to gene expression transitions, allowing for the programming of eight distinct cell "states" - combinations of On/Off states of 3 reporter genes - using a single bifunctional effector. This work establishes the theoretical framework and molecular mechanisms of pulse-generating gene regulation by bifunctional domains and creates a foundation for engineering complex multi-gene circuits.

22 October 2025 in bioRxiv
Verified
Preprint
Open access
CPCarla P. Perez
Carla P. Perez
NDNicole V. DelRosso
Nicole V. DelRosso
CNCameron Noland
Cameron Noland
UPUdit Parekh
Udit Parekh
CCChristian A. Choe
Christian A. Choe
PHPo-Ssu Huang
Po-Ssu Huang
Protein-protein interactions underpin most cellular interactions, and engineered binders present powerful tools for probing biology and developing novel therapeutics. One bottleneck in binder generation is the scalable, quantitative characterization of these interactions. We present ADAPT-M ( A ffinity D etermination by A daptation of P ro T ein binders for M icrofluidics), a streamlined workflow that connects yeast surface display (YSD) with in vitro affinity and kinetic measurements using the high-throughput STAMMPPING microfluidic platform. ADAPT-M quantifies K d s and dissociation kinetic parameters for hundreds of enriched protein variants in under one week without requiring hands-on protein purification. We applied ADAPT-M to a computationally designed library targeting the SARS-CoV-2 Omicron BA.1 receptor binding domain, successfully recovering and measuring K d s for most highly enriched YSD variants. Measurements correlate strongly with biolayer interferometry and yeast titration assays. ADAPT-M further enabled selection of lead candidates for structural and mutational analysis, which revealed designed paratopes were preserved despite binding to off-target epitopes. By bridging YSD screening and in vitro validation, ADAPT-M accelerates protein binder discovery and supports data-driven protein engineering.